85 assets in High Grade B-Cell Lymphoma

Etoposide

Isocyclophosphamide

Adriamycin

Prednisone

Vincristine Sulfate

Axicabtagene Ciloleucel

Dexasone

Rituximab

Bendamustine

Carboplatin

Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,461-Alanine,462-Alanine,556-Glycine,581-Cysteine,593-Tryptophan), Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 Vh-Ch1 Fragment) Fusion Protein With Peptide (Synthetic 10-Amino Acid Linker) Fusion Protein With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Heavy Chain Vl(.Lambda.)-Ch1-Ch2-Ch3), (222->219''')-Disulfide With Immunoglobulin Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)) And (447->232'')-Disulfide With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Light Chain Vh-Cl(.Kappa.)), (453->228'), (456->231'), (581->351')-Tris(Disulfide) With Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,236-Alanine,237-Alanine,331-Glycine,351-Cysteine,368-Serine,370-Alanine,409-Valine) Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Gamma.1-Chain) Disulfide With Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)

Venetoclax

(+)-Vincristine

Zanubrutinib

Cyclophosphamide

Pembrolizumab

Recombinant Human Hyaluronidase

Acalabrutinib

Cytarabine

Fludeoxyglucose

Golcadomide

Ibrutinib

Mosunetuzumab

Jcar-017 Cd19-Specific Chimeric Antigen Receptor

Obinutuzumab

Oxaliplatin

Polatuzumab Vedotin

Tafasitamab

Fludarabine

Lenalidomide

Talikabtagene Autoleucel

Azacitidine

Epcoritamab

Prednisolone

Anti-Cd20/Cd3 Monoclonal Antibody Regn1979

Busulfanum

Clofarabine

Conjugated Pneumococcal Vaccine

Nivolumab

Ontorpacept

Polatuzumab

Tacrolimus

Tazemetostat

Zamtocabtagene Autoleucel

Vorinostat

Autologous Cd4+ And Cd8+ T Cells, Enriched From Peripheral Blood Mononuclear Cells (Pbmcs) Transduced With A Nonreplicative Self-Inactivating (Sin) Lentiviral Vector Encoding A Chimeric Antigen Receptor (Car) Consisting Of The Human Cd19-Specific Scfv, An Lgg4 Hinge Region, Cd28 Transmembrane Domain, Cd137 (4-1Bb) Co-Stimulatory Domain And Cd3 Zeta Signalling Domain, Under The Control Of A Hybrid Elongation Factor 1 Alpha (Ef1.Alpha.) And Human T Cell Leukemia Virus Type 1(Htlv-1) Regulatory Element Promoter And Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Element (Wpre). The Vector Genome Also Encodes A Truncated Human Epidermal Growth Factor Receptor (Egfrt) That Is Co-Expressed With The Car And Cleaved From It By The T2A Self-Cleaving Peptide. The Vector Genome Also Contains A Splice Donor, A Fragment Of Gag, A Rev Response Element (Rre), A Mutated Central Polypurine Tract (Cppt), And A Splice Acceptor

Emapalumab

Sepantronium

CD47/SIRPA-BLOCKING AGENT ALX148

Interleukin 18 (Recombinant Human Mutein Clone St-067)